Natasha P Malkani,Vanita R Aroda
Natasha P Malkani
André J Scheen
André J Scheen
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial [0.03%]
德谷肽注射液对2型糖尿病成人胰岛功能和胰岛素敏感性的影响：一项多中心随机双盲平行对照I期临床试验
Tim Heise,Andrea Mari,J Hans DeVries et al.
Tim Heise et al.
Background: Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, shows a remarkable ability to lower blood glucose, enabling many patients with long-standing type 2 diabetes to ac...
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial [0.03%]
一项随机、开放标签、平行组、3期SURPASS-3试验的子研究：在成人2型糖尿病患者中，一周一次 tirzepatide与一日一次 insulin degludec控制血糖（连续葡萄糖监测法测量）疗效的比较（SURPASS-3 CGM）
Tadej Battelino,Richard M Bergenstal,Angel Rodríguez et al.
Tadej Battelino et al.
Background: Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist under development for the treatment of type 2 diabetes. In this study, we used continuous glucose monit...
Giovanni Targher
Giovanni Targher
Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study [0.03%]
印度糖尿病患者中推荐的糖尿病治疗目标和健康习惯的实现情况（ICMR-INDIAB-13）：一项全国性横断面研究
Ranjit Mohan Anjana,Ranjit Unnikrishnan,Mohan Deepa et al.
Ranjit Mohan Anjana et al.
Background: There is little information on comprehensive diabetes care comprising glycaemic, lipid, and blood pressure control in India; therefore, we aimed to assess the achievement of treatment targets among adults with...
Decision making in differences of sex development/intersex care in the USA: bridging advocacy and family-centred care [0.03%]
美国性别发育差异/间性诊疗决策：连接倡导与家庭中心式护理
David E Sandberg,Eric Vilain
David E Sandberg
Jennifer Manne-Goehler
Jennifer Manne-Goehler
Sam Egger,David P Smith,Visalini Nair-Shalliker
Sam Egger
Methodological considerations in D-health cancer mortality results - Authors' reply [0.03%]
关于D-健康癌症死亡率结果的方法学考虑——作者回信
Rachel E Neale,Briony Duarte Romero,Donald S A McLeod et al.
Rachel E Neale et al.